Claim Missing Document
Check
Articles

Found 2 Documents
Search

Treatment Evaluation of Melasma Patients in Dr. Hasan Sadikin General Hospital Bandung in period of 2013–2014 Ayu Adzani Sabila; Reti Hindritiani; Dimas Erlangga Luftimas
Althea Medical Journal Vol 3, No 4 (2016)
Publisher : Faculty of Medicine Universitas Padjadjaran

Show Abstract | Download Original | Original Source | Check in Google Scholar | Full PDF (271.598 KB)

Abstract

Background: Melasma is hyperpigmentation of the skin especially located on face exposed to the sunlight. This condition was characterized by brown to gray-brown macula with irregular border. Difficulties in treatment of melasma arise from high tendency for relapse, expensive cost, and high risk of side effects such as erythema, sores, scales, and acne eruption. Study about evaluation of melasma therapy in Dr. Hasan Sadikin General Hospital Bandung have not ever been done before. Therefore, this study was conducted to evaluate therapy of melasma in the Policlinic of Dermatology and Venereology, Dr. Hasan Sadikin General Hospital Bandung.Methods: This study was retrospectively descriptive. Data were obtained from the new melasma patient medical records of Policlinic of Dermatology and Venereology of Dr. Hasan Sadikin General Hospital Bandung in period of January 2013–2014. Sampling method used in this study was total sampling. Treatments of melasma were evaluated by using Melasma Area Severity Index (MASI) score. Collected data were processed and presented in frequency distribution and percentage.Results: The most used topical drugs were combination of hydroquinone and tretinoin, and all of patients received sunblock. Most frequent time interval was two weeks (30.8%). The most common side effect was erythema (10 out of 22). Decreased MASI score was discovered in 48.1% and the most decreased category was mild (14 out of 25). Conclusions: The very common topical drugs used are hydroquinone and tretinoin. The side effect of the treatment is Erythema. The decreased MASI score is mild. [AMJ.2016;3(4):610–5]DOI: 10.15850/amj.v3n4.947
Infeksi Cacar Monyet (Monkeypox) Larasati Budiyarto; Ayu Adzani Sabila; Hafizha Cyndriyani Putri
Jurnal Medika Hutama Vol. 4 No. 02 Januari (2023): Jurnal Medika Hutama
Publisher : Yayasan Pendidikan Medika Indonesia

Show Abstract | Download Original | Original Source | Check in Google Scholar

Abstract

Monkeypox virus is one of the zoonotic viruses belonging to the genus Orthopoxvirus of the family Poxviridae. Case of monkeypox infection in human, also known as monkeypox, was first discovered at the Republic of the Congo in 1970. Monkeypox infection was previously an endemic disease, especially in Africa. This disease has become a global concern since WHO received reports of monkeypox cases originating from non-endemic countries in May 2022. The clinical signs and symptoms of the current monkeypox outbreak are considered different with the previous classic manifestations. Transmission of the disease is currently dominated by sexual contact. The diagnosis of monkeypox can be established through PCR examination. The mortality rate of monkeypox infection is low but may cause various complications. Until now, no specific treatment has been found for monkeypox infection. Vaccination after exposure is found to lower risk of severity and death. It is important for clinicians to study and understand more about the disease, prevention, outbreak control efforts, and management of monkeypox disease. Keywords : infection, management, monkeypox, prevention, transmission